| Financial Year |
March 31 2023 |
| Monetary Funds |
5,398,515,730.62 |
| Held-for-trading Financial Assets |
3,530,266,020.82 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
-- |
| Other Receivables |
-- |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
-- |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,543,950,361.84 |
| Investment Properties |
1,047,926,500.00 |
| Fixed Assetes |
75,776,071.06 |
| Under-construction Projects |
419,906,580.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
388,116,375.35 |
| R&D expenses |
-- |
| Goodwill |
343,456,864.17 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
414,574,137.02 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
-- |
| Total Assets |
22,948,960,793.13 |
| Short-Term Loans |
2,539,967,462.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
267,062,787.42 |
| Taxes Payable |
18,925,426.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
-- |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
-- |
| Long-term Loans |
3,430,000,000.00 |
| Bonds Payable |
1,017,502,876.65 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
561,866.61 |
| Deferred Income Tax Liabilities |
3,751,506.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
17,891,046,803.98 |
| Paid-In Capital(Or Share Stock) |
896,000,000.00 |
| Capital Surplus |
705,991,687.37 |
| Surplus Reserve |
201,792,963.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
775,086,539.77 |
| Minority Stockholder's Interest |
2,205,752,208.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,852,161,780.47 |
| Owner's Equity（Stockholder's Equity） |
5,057,913,989.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,948,960,793.13 |
